German science and technology company Merck KGaA has launched a supercomputer in Germany. Housed in an Equinix data center in Germany, the system has been built on Lenovo ThinkSystem servers and will ...

Are you wondering if Merck KGaA is undervalued, overvalued, or finally priced just right? Let's demystify the numbers together and see if there's opportunity hiding beneath the surface. Despite its ...

Drugs that interfere with a way tumors repair damage to their DNA have become valuable tools for treating certain cancers. Some big pharmaceutical companies are developing drugs that improve on this ...

Despite a rocky start to the year for Merck KGaA’s contract development and manufacturing group, the German company is finding some reason to be optimistic about its recent performance. Last week, ...

Dr. Rasha Kelej highlighted the deepening collaboration between Merck Foundation and Cabo Verde, announcing that young ...

Big pharma performed well in 2022, but the time to trim is drawing close. As a more diversified investment, I believe former parent company of Merck & Co, Merck KGaA offers a better long-term ...

Thinking about picking up some Merck KGaA shares, but wondering if the current price tag does the business justice? You're not alone. Value hunters and long-term investors keep asking the same ...

Merck KGaA reaffirmed its strong performance in the healthcare sector in its FY 2024 earnings report, but provided little ...

After nearly two decades spent working with the World Health Organization (WHO) to supply billions of praziquantel tablets to help treat schistosomiasis, Merck KGaA has recently tacked on an ...

JPMorgan lowered the firm’s price target on Merck KGaA (MKKGY) to EUR 150 from EUR 155 and keeps an Overweight rating on the shares.TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for ...

Merck KGaA is bolstering its drug discovery efforts by turning to two artificial intelligence companies, BenevolentAI and Exscientia. Details are scant, but Merck KGaA said the multi-year agreements ...

Merck KGaA is an undervalued pharma company with a long history and strong fundamentals. The company has above-average margins and a diverse business portfolio in healthcare, life sciences, and ...